Cover Image
市場調查報告書

出血熱:全球臨床實驗檢討

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320836
出版日期 內容資訊 英文 59 Pages
訂單完成後即時交付
價格
Back to Top
出血熱:全球臨床實驗檢討 Hemorrhagic Fever Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 59 Pages
簡介

本報告提供出血環境熱能的臨床試驗相關之基本資料及數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 出血環境熱能
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:出血環境熱能的感染症臨床實驗上比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:出血環境熱能的感染症臨床實驗上比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗上目標達成情形

未完成的臨床實驗數量 出血環境熱能

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

出血熱治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • Sarepta Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Liaoning Cheng Da Biotechnology Co., Ltd
  • 有代表性的研究機關·醫院臨床實驗概要
    • U.S. Army Medical Research and Materiel Command
    • The National Institute of Allergy and Infectious Diseases
    • University of Maryland

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2449CTIDB

GlobalData's clinical trial report, "Hemorrhagic Fever Global Clinical Trials Review, H2, 2014" provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hemorrhagic Fever
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hemorrhagic Fever
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hemorrhagic Fever Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Sarepta Therapeutics, Inc.
      • Clinical Trial Overview of Sarepta Therapeutics, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Liaoning Cheng Da Biotechnology Co., Ltd
      • Clinical Trial Overview of Liaoning Cheng Da Biotechnology Co., Ltd
    • Clinical Trial Overview of Top Institutes / Government
      • U.S. Army Medical Research and Materiel Command
      • Clinical Trial Overview of U.S. Army Medical Research and Materiel Command
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Maryland
      • Clinical Trial Overview of University of Maryland
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Liaoning Cheng Da Biotechnology Co., Ltd, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2014*

List of Figures

  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top